Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM50 (TRIM50)

Target
TRIM50
Molecular classification
Enzyme (specifically E3 ubiquitin ligase), Tripartite motif (TRIM) family protein
01

Overview

E3 ubiquitin-protein ligase TRIM50 is a member of the tripartite motif (TRIM) protein family, characterized by a RING domain, B-box motif, and coiled-coil region[2]. TRIM50 acts as an E3 ubiquitin ligase, catalyzing the transfer of ubiquitin to substrate proteins by interacting preferentially with E2 conjugating enzymes such as UbcH8, UbcH6, and UbcH9 through its RING domain[2]. In cellular contexts, TRIM50 shows high specificity for gastric parietal cells; it is predominantly localized in tubulovesicular and canalicular membranes within these cells, contributing to vesicular trafficking and dynamics essential for gastric acid secretion[1]. TRIM50-associated vesicular movement is phosphoinositide 3-kinase (PI3K)-dependent and involves binding of its C-terminal PRY-SPRY domain to phosphatidylinositol phosphates. Knockout studies in mice show that loss of TRIM50 leads to impaired gastric acid secretion and abnormal vesicular morphology without affecting overall cell viability or the normal expression of acid-secretory machinery[1]. TRIM50 forms higher-order structures, possibly trimers, and localizes to cytoplasmic aggregates (aggresomes) that may be involved in protein quality control and degradation[2]. TRIM50's gene is located in a region deleted in Williams–Beuren syndrome, suggesting possible relevance to this disorder[2]. At present, TRIM50 has no known direct drug modulators or established therapeutic interventions, and its role as a biomarker or therapeutic target remains under investigation.

Other names
TRIM50AFLJ32804Tripartite motif-containing protein 50RING-type E3 ubiquitin transferase TRIM50Tripartite motif-containing 50A
02

Biological functions

Ubiquitination (mediated via E3 ligase activity)[2]Vesicular trafficking, especially in gastric parietal cells[1]Subcellular compartmentalization and aggregation (formation of cytoplasmic structures, possibly aggresomes)[2]
03

Disease associations

Williams–Beuren syndrome (located in a deleted region)[2]Other (no definitive disease associations established; possible implication in gastric acid secretion defects[1])

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM50 (TRIM50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM50 (TRIM50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call